Rekah Pharmaceutical Industry Ltd. (TLV:REKA)
Israel
· Delayed Price · Currency is ILS · Price in ILA 1,180.00
-29.00 (-2.40%)
Mar 9, 2026, 5:24 PM IDT
TLV:REKA Revenue
Rekah Pharmaceutical Industry had revenue of 75.07M ILS in the quarter ending September 30, 2025, a decrease of -13.90%. This brings the company's revenue in the last twelve months to 300.24M, down -9.46% year-over-year. In the year 2024, Rekah Pharmaceutical Industry had annual revenue of 321.71M with 0.02% growth.
Revenue (ttm)
300.24M
Revenue Growth
-9.46%
P/S Ratio
0.46
Revenue / Employee
713.17K
Employees
421
Market Cap
138.00M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 321.71M | 49.00K | 0.02% |
| Dec 31, 2023 | 321.66M | 29.27M | 10.01% |
| Dec 31, 2022 | 292.39M | 28.44M | 10.78% |
| Dec 31, 2021 | 263.95M | -1.52M | -0.57% |
| Dec 31, 2020 | 265.47M | 68.97M | 35.10% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 55.02B |
| Danel (Adir Yeoshua) | 2.87B |
| Kamada | 578.74M |
| BrainsWay | 162.56M |
| Geffen Residence & Renewal | 84.00K |
| Epitomee Medical | 37.17M |
| Golden House | 46.05M |
| InterCure | 243.12M |